Life science executive search in the Netherlands, for leaders who move the science.

Life sciences executive search in the Netherlands: C-level, VP and board-level appointments for biotech, pharma, CDMO and medtech companies. Confidential, senior-led and assessment-driven, with a target of a signed offer within 12 weeks of the brief. The candidate's notice period and onboarding follow from there.

Executive search for life sciences in the Netherlands, in short.

Axeleon is a European life sciences search partner, focused on the Netherlands. Our life science executive search finds CEOs, COOs, QA Directors, site heads and board members for pharma, biotech, CDMO and medtech companies. Russell Kerby runs every search himself. The target is a signed offer within 12 weeks of the brief, and if the appointed leader leaves within six months the search is rerun at no fee. The answers to the questions clients ask most are further down this page.

Partner-led, with the research capacity each mandate needs.

Russell Kerby leads every retained search: taking the brief, setting the search strategy, assessing shortlisted candidates and guiding the appointment. He combines recruitment experience dating back to 2006 with a life sciences specialism built since 2010. When a mandate requires wider geographic coverage or additional research capacity, experienced sourcing teams support market mapping and candidate identification under his direction. Clients continue to work directly with Russell throughout.

The work starts before the search does: understanding the real leadership problem behind the vacancy, aligning what the CEO, the board and the investors actually need, and defining a success profile everyone has signed. Only then does the mapping begin.

A leadership vacancy costs more than a fee.

An open COO, QA Director or site head delays milestones, stalls programmes and puts inspections at risk. A mis-hire costs a year. In a sector where the difference between a strong leader and an adequate one shows up in batch records, audit findings and investor confidence, the appointment is an operational decision as much as a people decision.

Senior-led, assessment-driven. Target: signed offer within 12 weeks.

The same process every time, so you always know what happens next and when. The target is a signed offer within 12 weeks of the brief; notice periods and onboarding come after it.

  1. Stage 1 of 4 · Wk 1

    Alignment

    Meetings with the CEO, board or investor, and the functional stakeholders the leader will work with. Site visit. One success profile and one candidate narrative, agreed before any approach is made.

6-month replacement guarantee

If the appointed leader leaves within six months, the search is rerun at no fee. Terms are set out in the engagement letter.

Confidential by default

The client is never named in public, and most approaches are made directly, in Axeleon's name and under the partner's direction, one conversation at a time. Any research or sourcing support works under the same confidentiality terms. Any advertising is agreed with the client first.

A written update every week

A written update and a call every week: who has been approached, who is in, who is out and why, backed by the market map, candidate assessments and comparison reporting.

The 12 weeks run from the day the scope, the salary range and the terms are agreed. Client interview availability and decision speed affect the pace, which is why interview slots are planned in week 1.

Evidence you can defend to the board.

Every shortlisted candidate is assessed against the success profile agreed in week 1, not against a job description.

  • Structured interviews. Russell interviews each candidate against the same criteria, drawn from the success profile, and writes up the evidence per criterion.
  • In-depth references. Taken by Russell with the candidate's consent before the offer, from people who have seen the candidate lead, not only from the names on the CV.
  • Psychometrics for leadership roles. Run by an independent, qualified assessor, with the instrument and the timing agreed in the alignment meeting.
  • Anything else the role needs. A case presentation, a site walk or a meeting with the investors, agreed at alignment so every candidate goes through the same steps.

You receive a written profile per shortlisted candidate and a comparison matrix that sets the finalists side by side against the success profile.

Which route fits the role?

Russell recommends one before you commit to either. Terms for each search are set out in writing.

Retained executive searchMid to senior search
SuitsC-level, VP and board roles; confidential replacements; thin or international marketsHead-of, director and senior specialist roles in a reachable market
ResearchA market map of 200–350 people, a longlist of 12–20Targeted approaches, network referrals and advertising where useful
StakeholdersAlignment with the CEO, board or investors before any approachThe brief and success profile agreed with the hiring manager
AssessmentStructured interviews, in-depth references, psychometrics by an external assessor, comparison matrixAn interview by Russell and a written note on fit and motivation per candidate
ExclusivityExclusiveRequested where parallel agencies would harm your reputation in a small market
ReportingA written update and a call every weekA written update every week
FeeA retained fee, set out in the engagement letterPayable only when the hire starts
After the startA first-quarter check-in and a 6-month replacement guaranteeOffer support until the contract is signed; guarantee terms agreed per search

Recent mandates, and how the brief shaped them.

QA Director after an inspection: interim first, permanent second

Interim quality lead placed first · permanent search once the site had stabilised

A manufacturing site came out of an inspection with findings against quality and validation, and the CEO wanted a permanent QA Director in place as fast as possible. Russell's advice was to separate two needs that had been folded into one brief. The immediate need was remediation expertise: someone who had led a site through inspection follow-up before and could start within weeks. The longer-term need was a QA Director to build and lead the function for years. He placed an interim quality lead to run the remediation, and started the permanent search once the site had stabilised, so the client could recruit for the long-term role rather than the emergency, and candidates could see where the function stood.

Chief Operating Officer search, paused at the intake call

Executive search · one profile agreed before any approach

In the intake call the CEO described an operator to run the plant and the investor described an executive to lead the company towards a sale. Russell suggested they agree one profile before any candidate was approached, because a search run on both would produce a shortlist that satisfied neither. They came back with a single profile, and the search ran on that.

One role that was two: Head of Quality and Regulatory

Executive search · role split and sequenced

A scale-up adding manufacturing to development wanted a single Head of Quality and Regulatory. At that stage the two remits pulled in different directions: building a GMP quality system for a new manufacturing operation was a full-time job in its own right, while the regulatory workload depended on a submissions calendar that was not yet fixed. Combining them would have meant one of the two getting less attention exactly when it mattered. The company hired a Head of Quality first, with senior regulatory support alongside, and made the regulatory leadership appointment later, once the submissions calendar was clear.

Site Director, mid-sized generic pharmaceutical manufacturer, Netherlands

Executive search · filled within twelve weeks

The profile was reworked with the senior management team before any approach: it added responsibilities the site actually needed and dropped requirements no credible candidate would meet. The search then ran on three fronts at once, direct approaches to mapped candidates, network referrals and a targeted advertisement agreed with the client, and the role was filled within twelve weeks.

Vice President Operations, biotech

Executive search · appointed against first-year outcomes

The role was rebuilt with the senior management team around what the operations leader had to achieve in the first year, rather than a list of qualifications. The search ran directly into the market, through the network and with a targeted advertisement agreed with the client, and the appointment was made against the rebuilt profile.

Chief Commercial Officer, life sciences

Executive search · a Sales Director brief reframed

The request was for a Director of Sales. The briefing showed a bigger job: someone who could engage credibly with C-level customers while leading more than ten people across senior account management, business development and marketing. Russell challenged whether the proposed title and seniority reflected that responsibility, and recommended positioning the search at Chief Commercial Officer level, with a profile combining executive presence, commercial strategy and leadership across several functions. That clarity shaped a focused search and a candidate suited to the full scope of the company's commercial needs. The role was filled at CCO level.

What a retained mandate buys.

  • Reach to senior and executive professionals across Europe, including the passive majority who never see a job advertisement.
  • A partner who understands R&D, GMP manufacturing, CDMO economics and scale-up pressure, and can talk to candidates in their own terms.
  • A transparent, structured process with defined milestones, weekly reporting and a comparison matrix that makes the final decision defensible to the board.
  • Reduced mis-hire risk through leadership assessment and culture-fit evaluation before candidates reach your calendar.
  • Offer and onboarding support so the appointment holds.

When to call.

  • Milestones slipping because a leadership seat has been open too long.
  • A portfolio company that needs a stronger executive to hit its value-creation plan.
  • A mis-hire that has to be recovered quietly and quickly.
  • A scale-up whose leadership has not kept pace with its headcount.
  • A quality, manufacturing or R&D function that needs a credible operator, not a caretaker.

Questions clients ask before a search.

What is executive search in life sciences?

Retained, partner-led search for the leaders of pharma, biotech, CDMO and medtech companies: CEO, COO, CMO, QA Director, site head, VP and board roles. The search is exclusive, confidential and assessment-driven, and it runs on a market map of 200–350 professionals across Europe rather than on job advertisements.

How long does an executive search take?

Target: signed offer within 12 weeks of the brief. The 12 weeks run from the day the scope, the salary range and the terms are agreed. Client interview availability and decision speed affect the pace, which is why interview slots are planned in week 1. The candidate’s notice period and onboarding follow after the signed offer.

Who runs the search?

Russell Kerby leads every retained search personally: he takes the brief, sets the strategy, assesses the shortlisted candidates and guides the appointment. Where a mandate needs more research capacity or wider geographic coverage, sourcing teams support him under his direction. You work directly with Russell throughout.

When is retained search the right route, and when is mid to senior search?

Retained search suits C-level, VP and board roles, confidential replacements and thin or international markets. Head-of, director and senior specialist roles in a reachable market fit mid to senior search, where the first shortlist arrives within 3 weeks maximum and the fee is payable only when the hire starts. Russell recommends one before you commit to either.

Is the search confidential?

Yes, by default. The client is never named in public, and most approaches are made directly, in Axeleon’s name, one conversation at a time. Any research or sourcing support works under the same confidentiality terms, and any advertising is agreed with you first.

What happens if the appointed leader leaves?

If the appointed leader leaves within six months, the search is rerun at no fee. The terms are set out in the engagement letter. After the start date, a structured check-in during the first quarter helps the leader land well.

What does a life sciences executive search firm cost?

Retained search runs on a retained fee set out in writing in the engagement letter before work starts, with no surprises later. For roles below board level there is also mid to senior search, where the fee is payable only when the hire starts. Russell recommends the right route in the first call.

Do you search for biotech CEOs and board members?

Yes. Axeleon searches for CEOs, COOs, CMOs, QA Directors, site heads and board members at biotech, pharma, CDMO and medtech companies, including succession and founder handovers. The search is confidential and the client is never named in public.

Do you only search in the Netherlands?

Axeleon is a European life sciences search partner, focused on the Netherlands. Dutch pharma, biotech, CDMO and medtech companies are the core of the work, and the market map reaches across Europe where the role needs it. Axeleon is based in Amsterdam.

Partner experience includesBatavia Biomanufacturing · Johnson & Johnson · Teva · Sanquin · Prothya Biosolutions · Bilthoven Biologicals · HAL Allergy · HALIX · +13 more →

Discuss a mandate in confidence.

A thirty-minute call with Russell. Bring the problem, not the job description; the profile comes out of the conversation.